… of five — and I actively biked, hiked and traveled together first as a family, then as empty nesters. Our … speech classes. I continue to hope that a new medication or combination of drugs will be developed to better control …

… Hirst (center) was recognized with our 2018 J. William Langston Award by MJFF CEO Dr. Todd Sherer (left) and SVP of … goals of The Michael J. Fox Foundation and the Parkinson's community," said MJFF Senior Vice President of Research … MJFF established the J. William Langston Award in 2006 to show appreciation for our hard-working advisors. Langston was …

… Objective/Rationale:  Loss of cardiac autonomic innervation is a near universal feature in … these studies could lead to a low-cost, non-invasive test for early pre-motor Parkinson’s disease. Project … will be used to assess the HRV. These will then be compared to a control population. Relevance to …

… of Cynapsus’ APL-130277, a fast-dissolving, under-the-tongue thin-film product containing apomorphine. This study will compare the pharmacokinetics of APL-130277 compared to … a thin-film strip (like a Listerine strip). The results showed that the blood concentrations of apomorphine were …

… Hotel Room Blocks Statement Regarding COVID-19: We recommend all guests be fully vaccinated to attend A Funny Thing Happened on the Way to Cure Parkinson's. However, at this time, proof of vaccination is not required …

… Parkinson’s researchers from 28 states gathered in Washington D.C. for The Michael J. Fox Foundation’s (MJFF) … researcher-advocates discussed what they’re working on now, how federal funding is critical to finding a cure for the … of options,” said Jonathan Jackson, PhD, Director of the Community, Access, Recruitment, and Engagement (CARE) …